Pyrrolo-triazine aniline compounds useful as kinase inhibitors

US7160883B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Alaric J. Dyckman · Lawrenceville, US
• John Hynes · Washington Crossing, US
• Katerina Leftheris · Skillman, US
• Chunjian Liu · Pennington, US
• Stephen T. Wrobleski · Whitehouse Station, US

Key dates

• Filing date: Apr 22, 2003
• Grant date: Jan 9, 2007
• Expiry date: Apr 22, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds having the formula (I),and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R1, R2, R3, R4, R5, R6, X and Z are as described in the specification.